InvestorsHub Logo
icon url

God_Father

02/24/21 5:17 PM

#81074 RE: Thorfius #81070

Thanks Thorfius, my M&A acumen needs to be brushened up here.

I think us becoming a subsidiary is the only thing that checks off all of the discrepancies.

The extinguishing debt, out-of-pocket funding, and "Outside investment" is such a huge gap. But you do raise very valid points that I agree with, in that if it was a buyout where Gilead would wholly-own ENZC would not make sense to uplist as we wouldn't be a publicly traded company at that point.
icon url

God_Father

02/24/21 5:18 PM

#81076 RE: Thorfius #81070

I'm learning so much from this.
icon url

redwing992006

02/24/21 5:25 PM

#81079 RE: Thorfius #81070

Great post. I was not aware of that. Does make a lot of sense where is the funding/money coming from? Can’t wait until it becomes public. Overall I feel ENZC Will continue to trend upward even before any significant news like that is released. The higher we are when that occurs, the greater the tremendous share price increase will be, in my opinion. There are a lot of eyes on this stock , Even more so with a gym craver tweets and mentioning the ticker symbol on his national show today. He does not know anything about the stock, seems to have just heard about it from many tweets today, but if he spends 10 minutes going through some of the DD, I would not be surprised to see our CEO interviewed on his show sometime. Either way, doesn’t matter about him/Jim, ENZC Sure price will be significantly higher next week, next month and next year, IMO
icon url

Mutat

02/24/21 6:17 PM

#81091 RE: Thorfius #81070

From the November 10th PR

The Company has also procured a commitment for funding of $500,000.00 and has received the first tranche of $250,000. These funds are earmarked for implementation of the planned combined operations and the initial steps of the merged business strategy of creating successful therapeutics against infectious diseases thereby increasing the value of the Company's extensive technology. The second Tranche of funding will be received upon completion of the business combination documents. As part of the initial $500,000.00 funding, the Company and certain of its current convertible debt holders have agree to a 30-day standstill on issuance of any additional shares from conversions of debt.